|
PPME1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.364400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.388600E-01 |
| Normal-vs-Stage2 |
7.061400E-01 |
| Normal-vs-Stage3 |
2.480300E-02 |
| Normal-vs-Stage4 |
3.551600E-01 |
| Stage1-vs-Stage2 |
4.189000E-01 |
| Stage1-vs-Stage3 |
1.445920E-02 |
| Stage1-vs-Stage4 |
5.291200E-01 |
| Stage2-vs-Stage3 |
1.502050E-02 |
| Stage2-vs-Stage4 |
2.474600E-01 |
| Stage3-vs-Stage4 |
2.893800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.274600E-01 |
| Normal-vs-AfricanAmerican |
7.908000E-01 |
| Normal-vs-Asian |
5.782400E-01 |
| Caucasian-vs-AfricanAmerican |
7.791600E-01 |
| Caucasian-vs-Asian |
8.187400E-01 |
| AfricanAmerican-vs-Asian |
8.800000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.155030E-01 |
| Normal-vs-Female |
6.607400E-01 |
| Male-vs-Female |
9.825500E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.403800E-01 |
| Normal-vs-Age(41-60Yrs) |
6.699600E-01 |
| Normal-vs-Age(61-80Yrs) |
9.377500E-02 |
| Normal-vs-Age(81-100Yrs) |
6.679300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.850400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.428300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.523870E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.154550E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.100300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.301700E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.065770E-02 |
| Classical-VS-Follicular |
6.489600E-01 |
| Classical-VS-Other |
3.644400E-01 |
| Classical-VS-Normal |
7.203200E-01 |
| Tall-VS-Follicular |
6.643700E-02 |
| Tall-VS-Other |
3.152100E-02 |
| Tall-VS-Normal |
2.269500E-02 |
| Follicular-VS-Other |
3.279000E-01 |
| Follicular-VS-Normal |
5.303200E-01 |
| Other-VS-Normal |
4.172000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.417000E-01 |
| Normal-vs-N1 |
1.378360E-02 |
| N0-vs-N1 |
5.071500E-02 |
|
|
